Aurora Cannabis (ACB)
(Real Time Quote from BATS)
$0.69 USD
-0.02 (-2.25%)
Updated Mar 24, 2023 11:36 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Aurora Cannabis Inc. (ACB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.61 | $2.94 | $0.90 | 126.76% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Aurora Cannabis Inc. comes to $1.61. The forecasts range from a low of $0.90 to a high of $2.94. The average price target represents an increase of 126.76% from the last closing price of $0.71.
Analyst Price Targets (12)
Broker Rating
Aurora Cannabis Inc. currently has an average brokerage recommendation (ABR) of 2.82 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 2.82 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, one is Strong Buy, representing 9.09% of all recommendations. A month ago, Strong Buy represented 9.09%.
Broker Rating Breakdown

Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 10 | 10 | 10 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.82 | 2.82 | 2.82 | 2.80 | 2.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | From | To |
---|---|---|---|---|
10/31/2022 | Canaccord Genui | Matt Bottomley | Hold | Hold |
10/31/2022 | Cantor Fitzgera | Pablo Zuanic | Strong Buy | Strong Buy |
10/31/2022 | Mkm Partners | William J Kirk | Not Available | Hold |
10/31/2022 | Bmo Capital Mkt | Tamy Chen | Not Available | Hold |
9/22/2022 | Atb Cap Markets | Frederico Gomes | Strong Sell | Hold |
9/21/2022 | Piper Sandler | Michael S Lavery | Hold | Hold |
9/2/2022 | Jefferies & Co. | Owen Bennett | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.82 |
ABR (Last week) | 2.82 |
# of Recs in ABR | 11 |
Average Target Price | $1.61 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 154 of 252 |
Current Quarter EPS Est: | -0.05 |